Are you searching for help with migraines and chronic headache pain?
Migraines are a common, disabling and often progressive disorder characterized by increased excitability of the central nervous system [1,2]. It occurs in 18% of women and 6% of men in the US with peak prevalence in individuals between the ages of 25 and 55 . Economic burden of migraine in the US is estimated to be approximately 13 billion annually  (Stokes and Lappin, 2010).
With this many people looking for relief from chronic migraine and headache pain, there has to be an alternative option to help.
There is an option – Neurofeedback.
Neurofeedback works to create more efficient brain wave connections to increase brain performance. This is done through positive reinforcement by watching a movie or playing a video game. Neurofeedback training strengthens a trainee’s brainwave patterns to reduce negative symptoms associated with migraines and chronic headaches, which aims to maximize a brain’s potential.
Neurofeedback has been featured in the news from a study conducted by Dr. Stokes. “The NBC news story focuses on one of her patients, Anedi Edelstein, who came to Dr. Stokes after a long history of medications for migraines. She had tried 10 different prescription drugs and was concerned about the side effects of drowsiness, which could affect driving with her young children. This story discusses how her migraines were impacted by neurofeedback training and reports that she is now migraine free.
Lynn Hertel, another of Dr. Stokes’ patients, is the focus of the ABC news story. Lynn, a flute teacher, was often unable to play music because of her migraines. The migraines were so debilitating that Lynn says, “I really didn’t have a life. I just survived between migraines.”Before trying neurofeedback, she had been though “countless treatments.” After neurofeedback training, Lynn reports that her migraines are “practically non-existent” (About Neurofeedback, 2017)”.
Dr. Stokes and Lappin’s (2010) study showed that, “All combined neuro and biofeedback interventions were effective in reducing the frequency of migraines with clients using medication resulting in a more favorable outcome (70% experiencing at least a 50% reduction in headaches) than just medications alone (50% experience a 50% reduction) and that the effect size of our study involving three different types of biofeedback for migraine (1.09) was more robust than effect size of combined studies on thermal biofeedback alone for migraine (.5). These non-invasive interventions may show promise for treating treatment-refractory migraine and for preventing the progression from episodic to chronic migraine.”
If you are sick and tired of the debilitating pain and want to regain your life back, please call us at (844) 272-4666 or go to www.BrainCoreUSA.com/Bookingand book a free neurofeedback session.
We want to meet you, hear your story and discuss options on how to help.
A free session is our way to provide you an opportunity to try neurofeedback and answer any questions you may have in a convenient and stress-free environment.
Lipton R, Bigal M. Migraine: epidemiology, impact and risk factors for progression. Headache.2005. pp. S3–S13. [PubMed] [Cross Ref]
Ambrosini A, deNoordhout AM, Sandor PS, Schoenen J. Electrophysiological studies in migraine: a comprehensive review of their interest and limitations. Cephalalgia. 2003;23(Suppl1):13–31. doi: 10.1046/j.1468-2982.2003.00571.x. [PubMed] [Cross Ref]
Lipton R, Bigal M, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–349. doi: 10.1212/01.wnl.0000252808.97649.21. [PubMed] [Cross Ref]
Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159:813–8. doi: 10.1001/archinte.159.8.813.[PubMed] [Cross Ref]
About Neurofeedback. <http://www.aboutneurofeedback.com/conditions/migraines/>
Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826281/>